Case Study: Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination (interactive) Page 1   

No previous pagePrev   NextNo next page ContentsOpen this tutorial's Contents page in a new window   PrefaceOpen the Series Preface page in a new window   Print AllIn a new window, see a composite of all the pages in this tutorial. It will have all sections expanded - ready to print.   HelpOpen the Help page in a new window. 
Find out how to run the tutorial:
 - what the +, -, ++, and -- icons mean,
 - what the commands on this line do,
 - how to print,
 - and more.
Study Source
Context
Use of biological weapons by terrorists is increasingly a concern in the United States.
Smallpox is one of the likely biological agents that have drawn the attention of the federal government. The U.S. federal government is producing and stockpiling smallpox vaccine in response to the threat.
In spite of its effectiveness, the vaccine contains a live virus that can potentially result in serious complications.
This study is an appraisal of the risks and benefits faced by a person living in the United States. It is designed to aid public officials in understanding the factors that affect the public's decision-making process regarding smallpox vaccination programs.
Methods
The Model
Decision Rule
Interactive Exercises
Results
Sensitivity Analysis
Policy Implications
No previous pagePrev   NextNo next page ContentsOpen this tutorial's Contents page in a new window   PrefaceOpen the Series Preface page in a new window   Print AllIn a new window, see a composite of all the pages in this tutorial. It will have all sections expanded - ready to print.   HelpOpen the Help page in a new window. 
Find out how to run the tutorial:
 - what the +, -, ++, and -- icons mean,
 - what the commands on this line do,
 - how to print,
 - and more.

Centers for Disease Control and Prevention
U.S. Department of Health & Human Services
Hosted by
Office of Workforce and Career Development
AcknowledgementsExpand this section
Contacts
Norbert Denil (Site design and production) 321-633-6150 ngd1@cdc.gov
Ara Zohrabyan (Technical content) 404-498-6322 aqz0@cdc.gov

Top
 
Top
 
Top